Alfa Cytology introduces comprehensive small molecule PARPi development services for combating various diseases.   Alfa Cytology, a developer of oncology innovation, has announced its latest venture small molecule Poly(ADP-ribose) polymerase inhibitor development services. This cutting-edge initiative represents a major advancement in creating more precise and...